PHARMCO II ApS: Financial statements 2025
CVR: 25202899
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity in the 2025 report amounted to DKK 107,079,000. The solvency ratio was 84.4%. The company had 66 employees in the financial year.
- Gross Profit
- DKK -56,000
- Profit/Loss
- DKK 34,432,000
- Equity
- DKK 107,079,000
- Total Assets
- DKK 126,817,000
- Employees
- 66
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -56 t. | 34.4 mio. | 107.1 mio. | 66 |
| 2024 | - | -50 t. | 7.1 mio. | 92.1 mio. | 77 |
| 2023 | - | -47 t. | 13 mio. | 85.1 mio. | 65 |
| 2022 | - | 0 | -1.7 mio. | 72.1 mio. | 63 |
| 2021 | - | 0 | 4.2 mio. | 73.8 mio. | 49 |
Official annual report
How creditworthy is PHARMCO II ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PHARMCO II ApS has published its annual report for 2024. Gross profit came to DKK -50,125, and the net result was DKK 7,096,622.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity in the 2025 report amounted to DKK 107,079,000.